PURPOSE: To compare 2-staged versus single-staged Baerveldt implantation in children with glaucoma. DESIGN: Retrospective observational case series. SUBJECTS: Children (<18 years of age) who underwent Baerveldt glaucoma drainage device (GDD) placement with at least 6 months of postoperative follow-up. METHODS: Review of patients with at least 6 months of follow-up who underwent 2-stage Baerveldt placement (n = 25) between 2010 and 2025 and diagnosis and age-matched controls who had 1-stage Baerveldt placement (n = 40). Demographics, ocular diagnoses and surgeries, and examination findings (best-corrected visual acuity [BCVA], intraocular pressure [IOP], and glaucoma medications) were collected. MAIN OUTCOME MEASURES: Success and survival of Baerveldt GDD (IOP 5-21 mmHg, no additional IOP-lowering surgeries, and no visually devastating complications), BCVA, IOP, and glaucoma medications. RESULTS: Children in the 2-stage Baerveldt and single-stage Baerveldt (control) groups showed no difference in age at surgery, type of glaucoma, prior glaucoma and intraocular surgeries, or length of follow-up. There was also no significant difference in BCVA, IOP, or number of glaucoma medications between the 2 groups before operation or at final follow-up. However, there were fewer patients whose vision worsened between the preoperative and final examinations in the staged group (P = 0.0011). In both groups, final IOP (P < 0.0001) and number of glaucoma medications (P < 0.05) were significantly decreased compared with the preoperative examination. Success at final follow-up was 64% in the 2-stage group and 60% in the controls, and there was no difference in survival curves (P = 0.6629). Greater number of prior glaucoma surgeries was associated with increased risk of failure (odds ratio, 1.7; 95% confidence interval, 1.4-2.2). CONCLUSIONS: Two-staged Baerveldt placement in children obtained IOP control on fewer medications and showed similar success and survival rates to children who underwent single-staged Baerveldt surgery. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
No takes yet. Share an insight, caveat, or question.
Bohnsack et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: